Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Cardiovasc Surg (Torino) ; 49(4): 461-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18665108

ABSTRACT

Thoracic aortic aneurysms and other thoracic aortic lesions may become life-threatening conditions if they remain untreated. Conventional open surgical reconstruction with placement of an interposition graft is regarded as a definitive form of treatment, but is associated with considerable operative morbidity and mortality. Thoracic aortic lesions involving the aortic arch require more complex surgical interventions necessitating cardiopulmonary bypass, and hypothermic circulatory arrest. Outcomes from this form of treatment have a reported early stroke and death rate of up to 25%. Thoracic endovascular aortic repair is a less invasive alternative for the treatment of many thoracic aortic lesions. The application of a thoracic endoprosthesis may be limited by the extent of involvement of the proximal thoracic aorta as coverage of arch vessel ostia may be necessary to obtain adequate proximal endograft fixation and aneurysm exclusion. In an effort to overcome proximal landing zone limitations imposed by arch vessel involvement, hybrid surgical-endovascular reconstructive and debranching bypass procedures have been performed to create a proximal landing zone of adequate length. Although these adjunctive techniques incorporate invasive surgical procedures, it is believed that minimizing the procedural invasiveness, by avoiding aortic cross-clamping and/or hypothermic circulatory arrest, morbidity and mortality outcomes can be improved especially in high-risk patients. Several surgical approaches and techniques have been described for various levels of aortic arch involvement with encouraging early and mid-term results, although the long-term durability of these hybrid surgical-endovascular procedures remains to be defined.


Subject(s)
Aorta, Thoracic/surgery , Aortic Diseases/surgery , Blood Vessel Prosthesis Implantation/methods , Aorta, Thoracic/pathology , Aortic Diseases/pathology , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/instrumentation , Carotid Artery, Common/surgery , Humans , Prosthesis Design , Stents , Subclavian Artery/surgery , Treatment Outcome
2.
Circ Res ; 88(11): 1196-202, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11397787

ABSTRACT

Connexin43 (Cx43) is the principal connexin isoform in the mouse ventricle, where it is thought to provide electrical coupling between cells. Knocking out this gene results in anatomic malformations that nevertheless allow for survival through early neonatal life. We examined electrical wave propagation in the left (LV) and right (RV) ventricles of isolated Cx43 null mutated (Cx43(-/-)), heterozygous (Cx43(+/)(-)), and wild-type (WT) embryos using high-resolution mapping of voltage-sensitive dye fluorescence. Consistent with the compensating presence of the other connexins, no reduction in propagation velocity was seen in Cx43(-/-) ventricles at postcoital day (dpc) 12.5 compared with WT or Cx43(+/)(-) ventricles. A gross reduction in conduction velocity was seen in the RV at 15.5 dpc (in cm/second, mean [1 SE confidence interval], WT 9.9 [8.7 to 11.2], Cx43(+/)(-) 9.9 [9.0 to 10.9], and Cx43(-/-) 2.2 [1.8 to 2.7; P<0.005]) and in both ventricles at 17.5 dpc (in RV, WT 8.4 [7.6 to 9.3], Cx43(+/)(-) 8.7 [8.1 to 9.3], and Cx43(-/-) 1.1 [0.1 to 1.3; P<0.005]; in LV, WT 10.1 [9.4 to 10.7], Cx43(+/)(-) 8.3 [7.8 to 8.9], and Cx43(-/-) 1.7 [1.3 to 2.1; P<0.005]) corresponding with the downregulation of Cx40. Cx40 and Cx45 mRNAs were detectable in ventricular homogenates even at 17.5 dpc, probably accounting for the residual conduction function. Neonatal knockout hearts were arrhythmic in vivo as well as ex vivo. This study demonstrates the contribution of Cx43 to the electrical function of the developing mouse heart and the essential role of this gene in maintaining heart rhythm in postnatal life.


Subject(s)
Arrhythmias, Cardiac/physiopathology , Connexin 43/deficiency , Heart Ventricles/physiopathology , Ventricular Dysfunction/physiopathology , Animals , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/embryology , Body Surface Potential Mapping , Cardiac Pacing, Artificial , Connexin 43/genetics , Connexin 43/metabolism , Connexins/genetics , Connexins/metabolism , Disease Models, Animal , Electrocardiography/methods , Electrophysiologic Techniques, Cardiac , Fluorescent Dyes , Heart Conduction System/physiopathology , Heart Rate , Heart Ventricles/chemistry , Heart Ventricles/embryology , Heterozygote , Homozygote , In Vitro Techniques , Mice , Mice, Inbred Strains , Mice, Knockout , Optics and Photonics , RNA, Messenger/analysis , RNA, Messenger/metabolism , Ventricular Dysfunction/embryology , Ventricular Dysfunction/genetics , Video Recording , Gap Junction alpha-5 Protein
3.
Circ Res ; 87(10): 929-36, 2000 Nov 10.
Article in English | MEDLINE | ID: mdl-11073890

ABSTRACT

Connexin40 (Cx40) is a major gap junction protein that is expressed in the His-Purkinje system and thought to be a critical determinant of cell-to-cell communication and conduction of electrical impulses. Video maps of the ventricular epicardium and the proximal segment of the right bundle branch (RBB) were obtained using a high-speed CCD camera while simultaneously recording volume-conducted ECGs. In Cx40(-/-) mice, the PR interval was prolonged (47.4+/-1.4 in wild-type [WT] [n=6] and 57.5+/-2.8 in Cx40(-/-) [n=6]; P<0.01). WT ventricular epicardial activation was characterized by focused breakthroughs that originated first on the right ventricle (RV) and then the left ventricle (LV). In Cx40(-/-) hearts, the RV breakthrough occurred after the LV breakthrough. Additionally, Cx40(-/-) mice showed RV breakthrough times that were significantly delayed with respect to QRS complex onset (3.7+/-0.7 ms in WT [n=6] and 6.5+/-0.7 ms in Cx40(-/-) [n=6]; P<0.01), whereas LV breakthrough times did not change. Conduction velocity measurements from optical mapping of the RBB revealed slow conduction in Cx40(-/-) mice (74.5+/-3 cm/s in WT [n=7] and 43.7+/-6 cm/s in Cx40(-/-) [n=7]; P<0.01). In addition, simultaneous ECG records demonstrated significant delays in Cx40(-/-) RBB activation time with respect to P time (P-RBB time; 41.6+/-1.9 ms in WT [n=7] and 55.1+/-1.3 ms in [n=7]; P<0.01). These data represent the first direct demonstration of conduction defects in the specialized conduction system of Cx40(-/-) mice and provide new insight into the role of gap junctions in cardiac impulse propagation.


Subject(s)
Connexins/metabolism , Heart Conduction System/physiology , Acetylthiocholine , Animals , Bundle of His/metabolism , Cardiac Pacing, Artificial , Connexins/deficiency , Connexins/genetics , Electrocardiography/methods , Gap Junctions/metabolism , Heart Rate/genetics , Heart Ventricles/metabolism , In Vitro Techniques , Mice , Mice, Knockout , Myocardium/metabolism , Purkinje Fibers/metabolism , Gap Junction alpha-5 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...